Caroline Robert

1.2k total citations · 1 hit paper
14 papers, 685 citations indexed

About

Caroline Robert is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Caroline Robert has authored 14 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 2 papers in Organic Chemistry. Recurrent topics in Caroline Robert's work include Melanoma and MAPK Pathways (6 papers), CAR-T cell therapy research (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Caroline Robert is often cited by papers focused on Melanoma and MAPK Pathways (6 papers), CAR-T cell therapy research (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Caroline Robert collaborates with scholars based in France, Australia and United States. Caroline Robert's co-authors include Florence Forbes, D. M. Titterington, Gilles Celeux, Michèle Prévost, Jean‐Baptiste Burnet, Sarah Dorner, Gertjan Medema, Patrick Smeets, Manuela Villion and Michael Smylie and has published in prestigious journals such as Journal of Clinical Oncology, Water Research and European Journal of Cancer.

In The Last Decade

Caroline Robert

12 papers receiving 655 citations

Hit Papers

Deviance information criteria for missing data models 2006 2026 2012 2019 2006 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Deviance information criteria for missing data models
    2006 629 citations Gilles Celeux, Florence Forbes et al. Bayesian Analysis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caroline Robert France 5 324 211 111 65 50 14 685
Andreas Brezger Germany 10 611 1.9× 289 1.4× 307 2.8× 84 1.3× 60 1.2× 13 1.3k
Nadja Klein Germany 15 307 0.9× 173 0.8× 152 1.4× 82 1.3× 39 0.8× 73 790
Kimberly F. Sellers United States 14 360 1.1× 170 0.8× 72 0.6× 87 1.3× 30 0.6× 42 986
Yongyi Min United States 6 382 1.2× 104 0.5× 90 0.8× 73 1.1× 33 0.7× 7 764
S. R. Paul Canada 18 591 1.8× 171 0.8× 51 0.5× 92 1.4× 33 0.7× 73 894
Stephen E. Fienberg United States 7 177 0.5× 125 0.6× 70 0.6× 49 0.8× 32 0.6× 8 713
Wenxin Jiang United States 14 314 1.0× 222 1.1× 81 0.7× 27 0.4× 75 1.5× 66 862
Katherine K. Wallman United States 8 427 1.3× 101 0.5× 51 0.5× 98 1.5× 25 0.5× 17 882
Y. Lee South Korea 7 630 1.9× 192 0.9× 136 1.2× 175 2.7× 102 2.0× 9 1.0k
Anthony Y. C. Kuk Singapore 22 1.2k 3.7× 467 2.2× 155 1.4× 137 2.1× 118 2.4× 64 1.6k

Countries citing papers authored by Caroline Robert

Since Specialization
Citations

This map shows the geographic impact of Caroline Robert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Robert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Robert more than expected).

Fields of papers citing papers by Caroline Robert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Robert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Robert. The network helps show where Caroline Robert may publish in the future.

Co-authorship network of co-authors of Caroline Robert

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Robert. A scholar is included among the top collaborators of Caroline Robert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Robert. Caroline Robert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bossard, Céline, Séverine Le Roy, Naima Benannoune, et al.. (2025). Use of artificial intelligence to identify high risk profiles in early stage melanoma patients from pathology slides.. Journal of Clinical Oncology. 43(16_suppl). 9579–9579.
2.
3.
Carlino, Matteo S., Naima Benannoune, Caroline Robert, et al.. (2022). Efficacy of ipilimumab 3mg/kg following progression on low dose ipilimumab in metastatic melanoma.. Journal of Clinical Oncology. 40(16_suppl). e21533–e21533. 1 indexed citations
4.
Khattak, Muhammad Adnan, Jason J. Luke, Georgina V. Long, et al.. (2022). Health-related quality of life (HRQoL) with pembrolizumab (pembro) in resected high-risk stage II melanoma in the phase 3 KEYNOTE-716 study.. Journal of Clinical Oncology. 40(16_suppl). 9581–9581. 3 indexed citations
5.
Svane, Inge Marie, Igor Puzanov, Caroline Robert, et al.. (2022). Randomized phase 3 trial of IO102-IO103 plus pembrolizumab versus pembrolizumab alone in patients with previously untreated, unresectable, or metastatic melanoma.. Journal of Clinical Oncology. 40(16_suppl). TPS9589–TPS9589. 2 indexed citations
6.
Wilmott, James S., Hiya Banerjee, Philippe Saïag, et al.. (2022). Association of baseline corticosteroid treatment with outcomes for patients (pts) with BRAF-mutant melanoma brain metastases (MBMs) in COMBI-MB treated with dabrafenib and trametinib (DT).. Journal of Clinical Oncology. 40(16_suppl). e21546–e21546.
7.
Dorner, Sarah, Jean‐Baptiste Burnet, Patrick Smeets, et al.. (2021). Changes in Escherichia coli to enteric protozoa ratios in rivers: Implications for risk-based assessment of drinking water treatment requirements. Water Research. 205. 117707–117707. 8 indexed citations
8.
Prévost, Michèle, Patrick Smeets, Gertjan Medema, et al.. (2020). Importance of Distributional Forms for the Assessment of Protozoan Pathogens Concentrations in Drinking‐Water Sources. Risk Analysis. 41(8). 1396–1412. 7 indexed citations
9.
10.
Rozeman, Elisa A., Alexander Christopher Jonathan Van Akkooi, Émilie Routier, et al.. (2017). Multicenter phase 2 study to identify the optimal neo-adjuvant combination scheme of ipilimumab (IPI) and nivolumab (NIVO) (OpACIN-neo).. Journal of Clinical Oncology. 35(15_suppl). TPS9600–TPS9600. 4 indexed citations
11.
Schadendorf, Dirk, Georgina V. Long, Jean‐Jacques Grob, et al.. (2017). PD-L1 and CD8 expression and association with outcomes in patients (pts) with BRAF V600E/K-mutant metastatic melanoma (MM) who received dabrafenib + trametinib (D+T) in the randomized phase 3 COMBI-v study.. Journal of Clinical Oncology. 35(15_suppl). 9527–9527. 2 indexed citations
12.
Eggermont, Alexander, Vanna Chiarion‐Sileni, Jean‐Jacques Grob, et al.. (2014). Ipilimumab versus placebo after complete resection of stage III melanoma: Initial efficacy and safety results from the EORTC 18071 phase III trial.. Journal of Clinical Oncology. 32(15_suppl). LBA9008–LBA9008. 18 indexed citations
13.
14.
Celeux, Gilles, Florence Forbes, Caroline Robert, & D. M. Titterington. (2006). Deviance information criteria for missing data models. Bayesian Analysis. 1(4). 629 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Brezger Breakdown of academic impact, for papers by Nadja Klein Breakdown of academic impact, for papers by Kimberly F. Sellers Breakdown of academic impact, for papers by Yongyi Min Breakdown of academic impact, for papers by S. R. Paul Breakdown of academic impact, for papers by Stephen E. Fienberg Breakdown of academic impact, for papers by Wenxin Jiang Breakdown of academic impact, for papers by Katherine K. Wallman Breakdown of academic impact, for papers by Y. Lee Breakdown of academic impact, for papers by Anthony Y. C. Kuk
Rankless by CCL
2026